Selective Cholinesterase Inhibitors from Buxus sempervirens L. and their Molecular Docking Studies

dc.contributor.authorOrhan, Ilkay E.
dc.contributor.authorKhan, Mahmud T. H.
dc.contributor.authorErdem, Sinem A.
dc.contributor.authorKartal, Murat
dc.contributor.authorSener, Bilge
dc.date.accessioned2026-02-06T18:19:26Z
dc.date.issued2011
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractIn this work, two alkaloids namely (+)-buxabenzamidienine (1) and (+)-buxamidine (2) were isolated from Buxus sempervirens, using bioassay-guided fractionation and isolation method. Their acetyl-(AChE) and butyrylcholinesterase (BChE) inhibitory activities were studied and the compounds were found to be quite selective inhibitors of AChE. IC50 values of compound 1 for electric eel AChE and horse BChE were 0.787 and 7.68 mM, respectively; while the corresponding IC50 of compound 2 were 1.70 and 549.98 mM, respectively. Theoretical (quantum mechanical, homology modelling and docking) calculations were performed in order to explain their interactions with different AChE (electric eel and human) and BChE (horse and human). The x-ray crystal structures of electric eel AChE, human AChE, human BChE and a model of horse BChE constructed by homology with human BChE were used for docking of compounds 1 and 2. Density functional theory (DFT) calculations of the compounds were performed at the B3LYP/6-31G** level using the program Spartan (TM), and their HOMO and LUMO energy levels were calculated. Docking studies exhibited that compound 1 interacts with the acyl-binding pocket of the active site gorge of huAChE, and including several other hydrophobic interactions.
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [104T492]; University of Tromso, Norway
dc.description.sponsorshipAuthors I.O., S. A., M. K., and B.S. acknowledge the financial grant for this work provided by The Scientific and Technological Research Council of Turkey (TUBITAK) through the research project coded as 104T492. M.T.H.K. acknowledges the financial supports from University of Tromso, Norway.
dc.identifier.endpage286
dc.identifier.issn1573-4099
dc.identifier.issn1875-6697
dc.identifier.issue4
dc.identifier.orcid0000-0002-7379-5436
dc.identifier.orcid0000-0003-3538-2769
dc.identifier.pmid22050684
dc.identifier.scopusqualityQ3
dc.identifier.startpage276
dc.identifier.urihttps://hdl.handle.net/11129/9073
dc.identifier.volume7
dc.identifier.wosWOS:000298590400007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofCurrent Computer-Aided Drug Design
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectAlzheimer's disease
dc.subjectacetylcholinesterase
dc.subjectbutyrylcholinesterase
dc.subjectdocking
dc.subjecthomology modeling
dc.titleSelective Cholinesterase Inhibitors from Buxus sempervirens L. and their Molecular Docking Studies
dc.typeArticle

Files